Skip to main content
Top
Published in: Clinical Rheumatology 6/2015

01-06-2015 | Original Article

Clinical features and types of articular involvement in patients with psoriatic arthritis

Authors: Salim Dönmez, Ömer Nuri Pamuk, Mustafa Akker, Recep Ak

Published in: Clinical Rheumatology | Issue 6/2015

Login to get access

Abstract

Psoriatic arthritis (PsA) is a psoriasis-associated inflammatory arthritis which causes joint destruction. There are some epidemiologic data about PsA; however, there are no sufficient data from Turkey. Herein, we evaluated the frequency of PsA in the Thrace region of Turkey according to hospital-based data. In addition, we evaluated clinical features and types of joint involvement in PsA patients. We included 172 PsA patients fulfilling CASPAR criteria admitted to the Division of Rheumatology, Trakya University Medical Faculty, between 2003 and 2012. Data from Turkish Statistical Institution was used to calculate the incidence and prevalence of PsA. Patients’ demographic features, durations of psoriasis and PsA, number of tender and swollen joints, treatment modalities, laboratory data, and X-ray film findings were recorded from hospital files. The annual incidence of PsA was 2.8/100,000. The mean annual incidence was 3.47/100,000 in females and 2.15/100,000 in males. The overall prevalence of PsA in our region was 27.9/100,000 (95 % confidence interval (CI) 23.7–32.1) in individuals >16 years. The prevalence of PsA was higher in females than in males (34.7/100,000 vs. 21.5/100,000). Polyarthritis was present in 67 (38.9 %), oligoarthritis in 47 (27.3 %), spondyloarthritis in 39 (22.6 %), and distal interphalangeal (DIP) arthritis in 19 (11.0 %) patients. The duration of psoriasis was significantly longer in polyarticular PsA patients than in DIP and oligoarticular groups (p values = 0.016 and 0.018, respectively). The number of swollen joints correlated with age (r = 0.21, p = 0.006), duration of psoriasis (r = 0.20, p = 0.01), number of tender joints (r = 0.92, p ≤ 0.001), ESR (r = 0.24, p = 0.001), and CRP (r = 0.17, p = 0.026). The frequency of PsA in Thrace region is similar to that in low-frequency regions. The most frequent type of involvement was polyarticular, and it correlated with the duration of psoriasis and erosive disease.
Literature
1.
go back to reference Duarte GV, Faillace C, Freire de Carvalho J (2012) Psoriatic arthritis. Best Pract Res Clin Rheumatol 26:147–156CrossRefPubMed Duarte GV, Faillace C, Freire de Carvalho J (2012) Psoriatic arthritis. Best Pract Res Clin Rheumatol 26:147–156CrossRefPubMed
2.
go back to reference Cantini F, Niccoli L, Nannini C, Kaloudi O, Bertoni M, Cassarà E (2010) Psoriatic arthritis: a systematic review. Int J Rheum Dis 13:300–317CrossRefPubMed Cantini F, Niccoli L, Nannini C, Kaloudi O, Bertoni M, Cassarà E (2010) Psoriatic arthritis: a systematic review. Int J Rheum Dis 13:300–317CrossRefPubMed
3.
go back to reference Sadek HA, Abdel-Nasser AM, El-Amawy TA, Hassan SZ (2007) Rheumatic manifestations of psoriasis. Clin Rheumatol 26:488–498CrossRefPubMed Sadek HA, Abdel-Nasser AM, El-Amawy TA, Hassan SZ (2007) Rheumatic manifestations of psoriasis. Clin Rheumatol 26:488–498CrossRefPubMed
4.
go back to reference Prey S, Paul C, Bronsard V, Puzenat E, Gourraud PA, Aractingi S et al (2010) Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literature. J Eur Acad Dermatol Venereol 24(Suppl 2):31–35CrossRefPubMed Prey S, Paul C, Bronsard V, Puzenat E, Gourraud PA, Aractingi S et al (2010) Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literature. J Eur Acad Dermatol Venereol 24(Suppl 2):31–35CrossRefPubMed
5.
go back to reference Onumah N, Kircik LH (2012) Psoriasis and its comorbidities. J Drugs Dermatol 11(5 Suppl):s5–s10PubMed Onumah N, Kircik LH (2012) Psoriasis and its comorbidities. J Drugs Dermatol 11(5 Suppl):s5–s10PubMed
6.
go back to reference Alamanos Y, Voulgari PV, Drosos AA (2008) Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol 35:1354–1358PubMed Alamanos Y, Voulgari PV, Drosos AA (2008) Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol 35:1354–1358PubMed
7.
go back to reference Salvarani C, Lo Scocco G, Macchioni P, Cremonesi T, Rossi F, Mantovani W et al (1995) Prevalence of psoriatic arthritis in Italian psoriatic patients. J Rheumatol 22:1499–1503PubMed Salvarani C, Lo Scocco G, Macchioni P, Cremonesi T, Rossi F, Mantovani W et al (1995) Prevalence of psoriatic arthritis in Italian psoriatic patients. J Rheumatol 22:1499–1503PubMed
8.
go back to reference Salvarani C, Olivieri I, Cantini F, Macchioni L, Boiardi L (1998) Psoriatic arthritis. Curr Opin Rheumatol 10:299–305CrossRefPubMed Salvarani C, Olivieri I, Cantini F, Macchioni L, Boiardi L (1998) Psoriatic arthritis. Curr Opin Rheumatol 10:299–305CrossRefPubMed
9.
go back to reference Kaipiaine S (1996) Incidence of psoriatic arthritis in Finland. Br J Rheumatol 35:1289–1291CrossRef Kaipiaine S (1996) Incidence of psoriatic arthritis in Finland. Br J Rheumatol 35:1289–1291CrossRef
10.
go back to reference Mathieu A, Cauli A, Vacca A, Mameli A, Passiu G, Porru G et al (2007) Genetics of psoriasis and psoriatic arthritis. Reumatismo 59(Suppl 1):25–27PubMed Mathieu A, Cauli A, Vacca A, Mameli A, Passiu G, Porru G et al (2007) Genetics of psoriasis and psoriatic arthritis. Reumatismo 59(Suppl 1):25–27PubMed
11.
go back to reference Creamer D, Jaggar R, Allen M, Bicknell R, Barker J (1997) Overexpression of the angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase in psoriatic epidermis. Br J Dermatol 137:851–855CrossRefPubMed Creamer D, Jaggar R, Allen M, Bicknell R, Barker J (1997) Overexpression of the angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase in psoriatic epidermis. Br J Dermatol 137:851–855CrossRefPubMed
12.
go back to reference Cakir N, Pamuk ON, Dervis E, Imeryüz N, Uslu H, Benian Ö et al (2012) The prevalences of some rheumatic diseases in western Turkey: Havsa study. Rheumatol Int 32:895–908CrossRefPubMed Cakir N, Pamuk ON, Dervis E, Imeryüz N, Uslu H, Benian Ö et al (2012) The prevalences of some rheumatic diseases in western Turkey: Havsa study. Rheumatol Int 32:895–908CrossRefPubMed
13.
go back to reference Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673CrossRefPubMed Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673CrossRefPubMed
14.
go back to reference Ogdie A, Langan S, Love T, Haynes K, Shin D, Seminara N et al (2013) Prevalence and treatment patterns of psoriatic arthritis in the UK. Rheumatology (Oxford) 52:568–575CrossRef Ogdie A, Langan S, Love T, Haynes K, Shin D, Seminara N et al (2013) Prevalence and treatment patterns of psoriatic arthritis in the UK. Rheumatology (Oxford) 52:568–575CrossRef
15.
go back to reference Silman AJ (2001) Psoriatic arthropathy. In: Silman AJ, Hochberg MC (eds) Epidemiology of the rheumatic diseases, 2nd edn, pp 85–99 Silman AJ (2001) Psoriatic arthropathy. In: Silman AJ, Hochberg MC (eds) Epidemiology of the rheumatic diseases, 2nd edn, pp 85–99
17.
go back to reference Madland TM, Apalset EM, Johannesen AE, Rossebo B, Brun JG (2005) Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway. J Rheumatol 32:1918–1922PubMed Madland TM, Apalset EM, Johannesen AE, Rossebo B, Brun JG (2005) Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway. J Rheumatol 32:1918–1922PubMed
18.
go back to reference Alamanos Y, Papadopoulos NK, Voulgari PV, Siozos C, Psychos DN, Tympanidou M et al (2003) Epidemiology of psoriatic arthritis in Northwest Greece, 1982–2001. J Rheumatol 30:2641–2644PubMed Alamanos Y, Papadopoulos NK, Voulgari PV, Siozos C, Psychos DN, Tympanidou M et al (2003) Epidemiology of psoriatic arthritis in Northwest Greece, 1982–2001. J Rheumatol 30:2641–2644PubMed
20.
go back to reference Gunal EK, Kamali S, Gul A, Ocal L, Konice M, Aral O et al (2009) Clinical evaluation and comparison of different criteria for classification in Turkish patients with psoriatic arthritis. Rheumatol Int 29:365–370CrossRefPubMed Gunal EK, Kamali S, Gul A, Ocal L, Konice M, Aral O et al (2009) Clinical evaluation and comparison of different criteria for classification in Turkish patients with psoriatic arthritis. Rheumatol Int 29:365–370CrossRefPubMed
21.
go back to reference Nossent JC, Gran JT (2009) Epidemiological and clinical characteristics of psoriatic arthritis in Northern Norway. Scand J Rheumatol 38:251–255CrossRefPubMed Nossent JC, Gran JT (2009) Epidemiological and clinical characteristics of psoriatic arthritis in Northern Norway. Scand J Rheumatol 38:251–255CrossRefPubMed
22.
go back to reference Soriano ER, Rosa J, Velozo E, Schpilberg M, Imamura PM, Diaz J et al (2011) Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: a 6-year health management organization-based study. Rheumatology (Oxford) 50:729–734CrossRef Soriano ER, Rosa J, Velozo E, Schpilberg M, Imamura PM, Diaz J et al (2011) Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: a 6-year health management organization-based study. Rheumatology (Oxford) 50:729–734CrossRef
23.
go back to reference Maejima H, Taniguchi T, Watarai A, Aki R, Katsuoka K (2010) Analysis of clinical, radiological and laboratory variables in psoriatic arthritis with 25 Japanese patients. J Dermatol 37:647–656CrossRefPubMed Maejima H, Taniguchi T, Watarai A, Aki R, Katsuoka K (2010) Analysis of clinical, radiological and laboratory variables in psoriatic arthritis with 25 Japanese patients. J Dermatol 37:647–656CrossRefPubMed
24.
go back to reference Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK (1987) Psoriatic arthritis (PSA)—an analysis of 220 patients. Q J Med 62:127–141PubMed Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK (1987) Psoriatic arthritis (PSA)—an analysis of 220 patients. Q J Med 62:127–141PubMed
25.
go back to reference Inanc N, Dalkilic E, Kamali S, Kasapoglu-Günal E, Elbir Y, Direskeneli H et al (2007) Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis. Clin Rheumatol 26:17–23CrossRefPubMed Inanc N, Dalkilic E, Kamali S, Kasapoglu-Günal E, Elbir Y, Direskeneli H et al (2007) Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis. Clin Rheumatol 26:17–23CrossRefPubMed
26.
go back to reference McGonagle D, Gibbon W, Emery P (1998) Classification of inflammatory arthritis by enthesitis. Lancet 352:1137–1140CrossRefPubMed McGonagle D, Gibbon W, Emery P (1998) Classification of inflammatory arthritis by enthesitis. Lancet 352:1137–1140CrossRefPubMed
27.
go back to reference Chandran V, Schentag CT, Gladman DD (2007) Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum 57:1560–1563CrossRefPubMed Chandran V, Schentag CT, Gladman DD (2007) Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum 57:1560–1563CrossRefPubMed
28.
go back to reference Helliwell PS, Porter G, Taylor WJ (2007) Polyarticular psoriatic arthritis is more like oligoarticular psoriatic arthritis, than rheumatoid arthritis. Ann Rheum Dis 66:113–117CrossRefPubMedCentralPubMed Helliwell PS, Porter G, Taylor WJ (2007) Polyarticular psoriatic arthritis is more like oligoarticular psoriatic arthritis, than rheumatoid arthritis. Ann Rheum Dis 66:113–117CrossRefPubMedCentralPubMed
Metadata
Title
Clinical features and types of articular involvement in patients with psoriatic arthritis
Authors
Salim Dönmez
Ömer Nuri Pamuk
Mustafa Akker
Recep Ak
Publication date
01-06-2015
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 6/2015
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-014-2746-4

Other articles of this Issue 6/2015

Clinical Rheumatology 6/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.